OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy
David Fernández‐Ramos, Fernando Lopitz‐Otsoa, Shelly C. Lu, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 535-535
Open Access | Times Cited: 1

NASH triggers cardiometabolic HFpEF in aging mice
Dániel Kucsera, Mihály Ruppert, Nabil V. Sayour, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 4517-4531
Open Access | Times Cited: 5

Up‐regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy
Mengru Bai, Mingyang Chen, Qingquan Zeng, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 17, pp. 4440-4456
Open Access | Times Cited: 20

The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition
Amir Abbas Momtazi‐Borojeni, Maciej Banach, Massimiliano Ruscica, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 10, pp. 1199-1208
Closed Access | Times Cited: 18

IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH
Dániel Kucsera, Viktória É. Tóth, Nabil V. Sayour, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10

Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome
Weixiao Niu, Yunyang Bao, Na Zhang, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105971-105971
Closed Access | Times Cited: 15

Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
Álvaro Santos‐Laso, María Gutiérrez‐Larrañaga, Marta Alonso‐Peña, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 46-46
Open Access | Times Cited: 18

Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 13

Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm?
Rosaria Vincenza Giglio, Emir Muzurović, Angelo Maria Patti, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2023) Vol. 28
Open Access | Times Cited: 6

Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison
Milena Vesković, M Pejović, Nikola Šutulović, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7405-7405
Open Access | Times Cited: 1

Protein restriction associated with high fat induces metabolic dysregulation without obesity in juvenile mice
Amélie Joly, Jean‐Louis Thoumas, Anne Lambert, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Protein restriction associated with high fat induces metabolic dysregulation without obesity in juvenile mice
Amélie Joly, Jean‐Louis Thoumas, Anne Lambert, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access

Page 1

Scroll to top